Viewing nowAcyclovir Tablet 200 mg (Acyclovir)
Acyclovir 200mg
Tablet · Prescription medication
Geonil Biopharm Co., Ltd.

MFDS item code 201907690 · Approved 2019.11.04 · Insurance code 073000990
Treatment and prevention of herpes simplex, treatment of chickenpox in children, and treatment of herpes zoster
This drug is effective in treating and preventing infections of the skin and mucous membranes caused by the herpes simplex virus. It can be used particularly for the treatment of primary and recurrent genital herpes. Additionally, it helps relieve acute pain during the treatment of herpes zoster virus infections. However, its effectiveness for postherpetic neuralgia is still not clearly proven. It can also be used for the treatment of chickenpox in children over 2 years old, making it widely utilized for various viral infection diseases.
Adults Treatment of herpes simplex virus infections: Administer acyclovir 200 mg per dose 5 times daily at 4-hour intervals for 5 days. Treatment may be extended for severe initial infections. In patients with severe immunocompromise (e.g., after bone marrow transplantation) or gastrointestinal malabsorption, the dose may be increased to 400 mg per administration or the route of administration may be changed to intravenous injection. It is preferable to start treatment as soon as possible after infection. For recurrent infections, treatment should preferably begin at the first sign of prodromal symptoms or lesions. Prevention of herpes simplex infections in immunocompetent patients: Administer this medicine 200 mg per dose 4 times daily at approximately 6-hour intervals. Alternatively, 400 mg per dose may be administered twice daily at 12-hour intervals. Thereafter, the dose may be reduced to 200 mg per dose 2 ~ 3 times daily after confirming efficacy. To determine the natural course of the disease, long-term treatment should be periodically discontinued for assessment every 6 ~ 12 months. Prevention of herpes simplex infections in immunocompromised patients: Administer this medicine 200 mg per dose 4 times daily at approximately 6-hour intervals. In patients with severe immunocompromise (e.g., after bone marrow transplantation) or gastrointestinal malabsorption, the dose may be increased to 400 mg per administration or the route of administration may be changed to intravenous injection. Administer during the period of risk of infection. Treatment of herpes zoster infections: Administer this medicine 800 mg per dose 5 times daily at approximately 4-hour intervals, excluding bedtime, for a total of 7 days. Intravenous administration should be considered in patients with severe immunocompromise or gastrointestinal malabsorption. It is preferable to start treatment as soon as possible after infection; the earlier the treatment, the better the effect. Because patients with renal impairment are more likely to experience neuropsychiatric adverse reactions, use caution, for example by extending the dosing interval or reducing the dose. Treatment of herpes simplex infections: The oral dose is generally not higher than the accumulated dose resulting from intravenous administration. However, in patients with severe renal impairment (creatinine clearance less than 10 mL per minute), it is preferable to administer this medicine 200 mg every 12 hours. Treatment of herpes zoster virus infections: For patients with creatinine clearance less than 10 mL per minute, it is preferable to reduce the dose to 800 mg per administration twice daily, at approximately 12-hour intervals. For patients with creatinine clearance of 10 ~ 25 mL per minute, it is preferable to reduce the dose to 800 mg per administration 3 times daily, at approximately 8-hour intervals.
Treatment of herpes simplex infections and prevention of herpes simplex infections in immunocompromised patients — 2 years and older: Same as adults. Treatment of herpes simplex infections and prevention of herpes simplex infections in immunocompromised patients — under 2 years: Administer 1/2 the adult dose. Treatment of chickenpox in children 2 years and older: Administer this medicine 20 mg per kg of body weight per dose (maximum 800 mg per dose) 4 times daily for 5 days. Treatment should be started as soon as possible after the chickenpox rash appears, preferably within 24 hours of rash onset.
This drug should not be used in patients with hypersensitivity or a specific genetic lactose metabolism disorder. Patients with kidney or liver dysfunction should use this medication with caution, and children or the elderly should also be administered carefully. While rare, serious allergic reactions or shock can occur with this medication, so symptoms should be monitored closely. If hypersensitivity reactions such as skin rash, fever, or urticaria occur, discontinue use immediately and seek appropriate measures. Various side effects can occur, including neurological symptoms, renal dysfunction, blood abnormalities, liver dysfunction, and gastrointestinal issues, so any unusual symptoms should be reported. To enhance therapeutic efficacy, it is important to administer this medication at the first sign of symptoms, and patients with weakened immunity may consider intravenous treatment. During treatment with this drug, it is essential to consume adequate fluids to prevent dehydration and renal toxicity. Caution is needed when operating vehicles or hazardous machinery, as impaired consciousness can occur. When used in combination with other medications, the concentration of this drug may change or the risk of side effects may increase, so it is essential to inform healthcare providers. Women who are pregnant or may become pregnant should use this drug with caution, and breastfeeding should be discontinued while on this medication. In children or the elderly, it should be administered at the minimum effective dose only when necessary. In case of overdose, severe neurological symptoms and kidney damage can occur, requiring immediate medical assistance, and blood dialysis may be necessary. In some studies, high doses have been reported to potentially cause genetic anomalies, although it is known to be safe at standard dosages.
Not everyone experiences these, and they can vary from person to person.
Store this medication in a tightly closed container to protect it from air and moisture. It is also recommended to keep it in a cool, dry place below 25 degrees Celsius.
Light blue round tablet
30 tablets/bottle, 100 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowAcyclovir 200mg
Tablet · Prescription medication
Geonil Biopharm Co., Ltd.

Acyclovir 200mg
Tablet · Prescription medication
Kyung dong Pharm Co., Ltd.

Acyclovir 200mg
Tablet · Prescription medication
SK Chemicals Co., Ltd.
Acyclovir
Prescription medication
Baskan Biopharmaceutical Co., Ltd.
Acyclovir 50mg
Cream · OTC medication
Dongkwang Pharmaceutical Co., Ltd.

Acyclovir 400mg
Tablet · Prescription medication
Kyung dong Pharm Co., Ltd.
Acyclovir 50mg
Cream · OTC medication
Kyungdong Pharmaceutical Co., Ltd.

Acyclovir 200mg
Tablet · Prescription medication
Vivozon Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.